Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene map may unlock better pancreatic cancer care

NCT ID NCT02869802

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times

Summary

This study aims to understand how gene changes in metastatic pancreatic cancer relate to treatment response. Researchers will analyze tumor samples from 190 adults starting chemotherapy. The goal is to see if returning genetic results within 8 weeks is feasible, which could help personalize future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BC Cancer - Vancouver

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

  • Cross Cancer Institute

    WITHDRAWN

    Edmonton, Alberta, T6G 1Z2, Canada

  • The Ottawa Hospital

    ACTIVE_NOT_RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

  • Tom Baker Cancer Centre

    RECRUITING

    Calgary, Alberta, T2N 4N2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.